Jiaxin Liu

Jiaxin Liu

Auto-generated profile, based on publicly available information

Jiaxin Liu

Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong (J.L., T.Y., Y. Liu)

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Stroke
Verified
Journal Article
Closed access
PDF file
JLJiaxin Liu
Jiaxin Liu
NLNing Li
Ning Li
ZZZhiyuan Zhu
Zhiyuan Zhu
KKKarrie M. Kiang
Karrie M. Kiang
ANAnson Cho Kiu Ng
Anson Cho Kiu Ng
Gilberto LeungGilberto Leung
Gilberto Leung
Background: Erythrophagocytosis by reparative monocyte-derived macrophage contributes to hematoma clearance and neurological recovery after intracerebral hemorrhage (ICH). Vitamin D (VitD) is a neuroprotective hormone and regulates the differentiation of monocyte-derived macrophage from monocytes. In this study, we examined the effects of VitD supplementation on monocyte-derived macrophage and hematoma clearance in rodent with ICH. Methods: Neurobehavioral functions and hematoma volume were assessed using a collagenase injection model in both young- and middle-aged mice with or without VitD treatment given 2 hours post-ICH induction. We used flow cytometry to analyze CD36 expression and macrophage and undifferentiated monocyte cell numbers during in vivo erythrophagocytosis in collagenase and autologous blood injection models. Western blot analysis and immunofluorescence were used to assess the expression levels of the PPAR-γ (peroxisome proliferator-activated receptor γ)-CD36 axis and CD206. A macrophage differentiation study was conducted on murine bone marrow-derived monocytes. Results: VitD promoted neurological recovery and facilitated hematoma clearance in both young- and middle-aged mice after ICH. Within the perihematomal region, mature macrophages, rather than undifferentiated monocytes, expressed higher levels of CD36 in driving erythrocyte clearance. VitD increased the macrophage number but decreased the monocyte number and elevated the levels of CD36 and PPAR-γ in the brain. In vitro, VitD accelerated the differentiation of reparative macrophages from bone marrow-derived monocytes. Conclusions: VitD promotes reparative macrophage differentiation, facilitates hematoma clearance, and improves neurobehavioral performance in mice with ICH, suggesting that VitD should be further examined as a potentially promising treatment for ICH.

1 January 2023 in Stroke
Verified
Journal Article
Closed access
PDF file
HLHo Chi Joseph Lai
Ho Chi Joseph Lai
JLJiaxin Liu
Jiaxin Liu
TYTian Yang
Tian Yang
JHJianpan Huang
Jianpan Huang
YLYang Liu
Yang Liu
Kannie WY ChanKannie WY Chan
Kannie WY Chan
Background: Noninvasive imaging of molecular alterations after intracerebral hemorrhage (ICH) could provide valuable information to guide and monitor treatments. Chemical exchange saturation transfer (CEST) magnetic resonance imaging has demonstrated promises in identifying proliferation, necrosis, and changes in cellularity in brain tumors. Here, we applied CEST magnetic resonance imaging to monitor molecular changes in hematoma without and with treatment noninvasively over 2 weeks at 3T using endogenous contrast. Methods: CEST contrast related to proteins at 3.5 ppm (amide proton transfer) and proteins/lipids at −3.5 ppm (relayed nuclear overhauser effect [rNOE]) were examined over 14 days in a collagenase-induced ICH mouse model. Imaging findings were validated with immunohistochemistry based on the ICH neuropathology. We also examined iron-containing phantoms that mimicked iron concentrations in hematoma to ensure the iron will not attenuate the CEST contrast during disease progression. Based on the validity of the CEST contrast of hematoma, we further examined related molecular alterations under iron-chelation treatment with deferoxamine. Results: We observed the temporal and spatial differences of CEST contrasts between rNOE at −3.5 ppm and amide proton transfer at 3.5 ppm, in which the core and perihematoma could be identified by rNOE on day 3 and day 14, and amide proton transfer on day 1, day 7, and day 14. Moreover, we observed a 25.7% significant reduction ( P <0.05) of rNOE contrast after deferoxamine treatment to the ICH mice on day 3, which was not observable in amide proton transfer contrast. Our histology data indicated that rNOE primarily correlated with the myelin pathology, and amide proton transfer could reflect the cellularity increase at hematoma up to day 7. Conclusions: Significant rNOE changes correlated well with histologic findings, especially myelin lipids, and regional characteristics in hematoma indicate the uniqueness of CEST magnetic resonance imaging in monitoring molecular changes during ICH and treatment.

1 March 2022 in World Neurosurgery
Verified
Journal Article
Closed access
NLNing Li
Ning Li
CCCharlene Y.C. Chau
Charlene Y.C. Chau
JLJiaxin Liu
Jiaxin Liu
MYMin Yao
Min Yao
KKKarrie M. Kiang
Karrie M. Kiang
Gilberto LeungGilberto Leung
Gilberto Leung